Clinical Trial Update: Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 results evaluate the efficacy and safety of extended olanzapine treatment for manic or mixed episodes in bipolar I disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Manic or Mixed Episode Associated With Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-06-29